Sterling Investment Advisors (Pennsylvania)’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-833
| Closed | -$4K | – | 550 |
|
|
2022
Q2 | $4K | Hold |
833
| – | – | ﹤0.01% | 470 |
|
|
2022
Q1 | $6K | Hold |
833
| – | – | ﹤0.01% | 485 |
|
|
2021
Q4 | $6K | Hold |
833
| – | – | ﹤0.01% | 480 |
|
|
2021
Q3 | $10K | Hold |
833
| – | – | ﹤0.01% | 438 |
|
|
2021
Q2 | $22K | Hold |
833
| – | – | 0.01% | 345 |
|
|
2021
Q1 | $24K | Hold |
833
| – | – | 0.01% | 317 |
|
|
2020
Q4 | $13K | Hold |
833
| – | – | ﹤0.01% | 346 |
|
|
2020
Q3 | $8K | Hold |
833
| – | – | ﹤0.01% | 361 |
|
|
2020
Q2 | $18K | Hold |
833
| – | – | 0.01% | 309 |
|
|
2020
Q1 | $15K | Buy |
833
+416
| +100% | +$7.49K | 0.01% | 294 |
|
|
2019
Q4 | $49K | Hold |
417
| – | – | 0.02% | 213 |
|
|
2019
Q3 | $38K | Buy |
+417
| New | +$38K | 0.02% | 234 |
|